癌症和败血症的发生
Jeroson C Williams1,2, Mandy L Ford1,3, Craig M Coopersmith1,2
1Department of Surgery, Emory University School of Medicine, Atlanta, GA 30322, U.S.A.
Clinical science (London, England : 1979)
|June 14, 2023
概括
由于复杂的免疫相互作用,癌症患者面临更高的败血症死亡率. 了解这些机制是个性化重症监护室 (ICU) 治疗策略的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 临界护理医学 临界护理医学
背景情况:
- 败血症是全球主要的死亡原因,癌症患者的死亡率显著上升.
- 癌症及其治疗方法可能会损害免疫功能,增加败血症的易感性和严重性.
- 临床前证据表明,癌症本身会加剧败血症死亡率,涉及适应性免疫失调.
研究的目的:
- 调查导致血症癌症患者死亡率增加的多因素机制.
- 探索癌症,败血症和免疫系统之间的双向关系.
- 评估新型治疗策略的潜力,如检查点抑制,在癌症和败血症的背景下.
主要方法:
- 对癌症对败血症结果影响的临床前数据的审查.
- 对癌症和败血症同时发生的免疫系统调节障碍的分析.
- 在临床前癌症-败血症模型中检查点抑制功效的检查.
主要成果:
- 癌症显著增加了败血症的死亡率,由免疫系统的改变介导.
- 败血症会影响瘤生长,而瘤免疫力会影响败血症的存活率.
- 检查点抑制研究揭示了单独无法预测的复杂相互作用.
结论:
- 了解癌症对败血症的机械影响对于个性化重症监护至关重要.
- 新型治疗方法需要仔细考虑癌症-败血症相互作用.
- 在ICU的精准医学需要更深入地了解癌症等并发病状况.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Psychoneuroimmunology: Diabetes and Cancer
50
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
50
Cancer
48.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.8K
What is Cancer?
10.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.8K
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Selectins
3.4K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.4K


